Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pigmented villonodular synovitis. Pedal manifestations

J H Walter1, J Galitz, D W Robertson

  • 1Department of Podiatric Orthopedics, Pennsylvania College of Podiatric Medicine, Philadelphia 19107.

Journal of the American Podiatric Medical Association
|November 1, 1994
PubMed
Summary

Pigmented villonodular synovitis, though benign, can cause bone destruction and prolonged recovery. Management challenges include recurrent pain and the need for multiple surgeries.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The complete European guidelines on phenylketonuria: diagnosis and treatment.

Orphanet journal of rare diseases·2017
Same author

Erratum to: Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

JIMD reports·2016
Same author

Treatment with Mefolinate (5-Methyltetrahydrofolate), but Not Folic Acid or Folinic Acid, Leads to Measurable 5-Methyltetrahydrofolate in Cerebrospinal Fluid in Methylenetetrahydrofolate Reductase Deficiency.

JIMD reports·2016
Same author

Unsuccessful treatment of severe pyruvate carboxylase deficiency with triheptanoin.

European journal of pediatrics·2013
Same author

Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters.

Journal of inherited metabolic disease·2009
Same author

Genes, patients, families, doctors-mutation analysis in clinical practice.

Journal of inherited metabolic disease·2009

Area of Science:

  • Orthopedic Surgery
  • Musculoskeletal Oncology

Background:

  • Pigmented villonodular synovitis (PVNS) is a rare, benign neoplastic proliferation of the synovium.
  • PVNS can lead to significant joint damage and functional impairment.

Observation:

  • The condition poses management challenges due to its potential for osseous destruction.
  • Treatment often involves multiple surgical interventions.

Findings:

  • Prolonged non-weightbearing periods are frequently required post-surgery.
  • Recalcitrant pain, often due to nerve impingement, is a common sequela.

Implications:

  • Effective management strategies are needed to minimize morbidity.
  • Further research into less invasive treatments and pain management is warranted.

Related Experiment Videos